Synthesis of symmetrical 1,5-bis-thio-substituted anthraquinones for cytotoxicity in cultured tumor cells and lipid peroxidation.

The synthesis of a series of anthraquinone moieties bearing symmetrical sulfur-linked substituents in the 1 and 5 positions is described. These compounds were evaluated for their ability to inhibit the growth of suspended rat glioma C6 cells and human hepatoma G2 cells, respectively. In addition, the redox property of the compounds was determined based on the inhibition of lipid peroxidation in model membranes. Compounds 2a and 2h in this series compared favorably and exhibited the most potent cytotoxicity (0.02, 0.05 microM) against C6 cells in the XTT colorimetric assay. As far as redox properties are concerned, all bis-thio-anthraquinones show potential lipid peroxidation in model membranes very close to that of mitoxantrone (MX), and 2a, 2d, 2e, 2i, 2j, and 2k have more potential than that of MX. The lack of cytotoxicity of compound 2i cannot be related to lipid peroxidation, but the steric and electronic properties of the side-chain substituent maybe impair effective recognition of the cleavable complex. In contrast to MX, 2a and 2h are cytotoxic in rat glioma C6 cells and do not enhance lipid peroxidation in model membranes.

[1]  J. Chiou,et al.  Synthesis and Cytotoxicity of 9‐Alkoxy‐1, 5‐dichloroanthracene Derivatives in Murine and Human Cultured Tumor Cells , 2002, Archiv der Pharmazie.

[2]  H. Huang,et al.  Studies on anthracenes. 3. Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives. , 2001, Chemical and pharmaceutical bulletin.

[3]  H. Chiu,et al.  Studies on anthracenes. 2. Synthesis and cytotoxic evaluation of 9-acyloxy 1,8-dichloroanthracene derivatives. , 2001, Chemical & pharmaceutical bulletin.

[4]  Y. Jen,et al.  Studies on anthracenes. 1. Human telomerase inhibition and lipid peroxidation of 9-acyloxy 1,5-dichloroanthracene derivatives. , 2001, Chemical & pharmaceutical bulletin.

[5]  F. Chang,et al.  Aromin-A, an Annonaceous acetogenin from Annona cherimola. , 1999, Phytochemistry.

[6]  G. Capranico,et al.  DNA sequence selectivity of topoisomerases and topoisomerase poisons. , 1998, Biochimica et biophysica acta.

[7]  E. Uriarte,et al.  Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. , 1996, Journal of medicinal chemistry.

[8]  H. Huang,et al.  Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis. , 1996, Journal of medicinal chemistry.

[9]  C. Teng,et al.  N-allylsecoboldine as a novel antioxidant against peroxidative damage. , 1996, European journal of pharmacology.

[10]  M. Schara,et al.  Reduction of nitroxides by anthralin and some of its derivatives. , 1995, Free Radical Biology & Medicine.

[11]  F. Zunino,et al.  Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin. , 1994, The Journal of biological chemistry.

[12]  F. Zunino,et al.  Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavage , 1994, Journal of molecular recognition : JMR.

[13]  F. Zunino,et al.  Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance. , 1994, Molecular pharmacology.

[14]  J. Gutteridge,et al.  Free radicals in disease processes: a compilation of cause and consequence. , 1993, Free radical research communications.

[15]  C. Manzotti,et al.  Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones. , 1991, Journal of medicinal chemistry.

[16]  M. Hacker,et al.  Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones. , 1990, Journal of medicinal chemistry.

[17]  B. Halliwell,et al.  Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. , 1986, Archives of biochemistry and biophysics.

[18]  P. Gregory,et al.  Organic Chemistry in Colour , 1983 .

[19]  R. Angier,et al.  Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones. , 1979, Journal of medicinal chemistry.

[20]  R. K. Zee-Cheng,et al.  Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity. , 1979, Journal of medicinal chemistry.

[21]  R. K. Zee-Cheng,et al.  Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones. , 1978, Journal of medicinal chemistry.